Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Total 13F shares
-
15,880
-
Share change
-
0
-
Total reported value
-
$321,729
-
Price per share
-
$20.26
-
Number of holders
-
1
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q4 2023
As of 31 Dec 2023 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,880 shares of stock of the company.
Largest 10 holders included VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, BlackRock Inc., VR Adviser, LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, VANGUARD GROUP INC, MORGAN STANLEY, and STATE STREET CORP.
This table shows 111 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.